Introduction {#s1}
============

Kidney development starts from two embryonic structures, the metanephric mesenchyme (MM) and the ureteric bud (UB) ([@bib31]). The Metanephric Mesenchyme gives rise to tubules organized in segments, each with a single type of epithelial cell. The UB, in contrast, gives rise to tubules containing mixtures of two different paradigmatic cell types called principal cells (PC) and intercalated cells (IC). These two cell types have different functions and they express different sets of signature proteins. PCs control water and electrolyte balance and express ion-channels such as ROMK, ENaC and Aquaporins 2--4 ([@bib48]). ICs, on the other hand, control acid-base balance ([@bib17]) and contribute to immune defense ([@bib43]; [@bib5]). ICs express vacuolar H^+-^-ATPase, including kidney specific subunits (D-B subunits), bicarbonate conversion enzymes (carbonic anhydrase *Ca2* and *Ca12*), bicarbonate transporters, AE1 (*Slc4a1*), AE4 (*Slc4a4*) and pendrin (*Slc26a4*). Nonetheless, despite their many differences, ICs and PCs function coordinately: for example, the absorption of Na^+^ by PCs creates a transepithelial electrical gradient which stimulates H^+^ secretion by ICs ([@bib10]; [@bib14]).

The underlying mechanisms that allow ICs and PCs to coordinate their activities have been difficult to identify because their genesis from progenitors and their ultimate relatedness to one another has been uncertain. This is because the collecting duct is thought to be populated by many subtypes of ICs, including α-IC and β-IC, non-α-β-IC, and various mixed cell types ([@bib51]) interspersed among PCs. Yet the definition of these various ICs and their relationship to PCs has been called into question as one cell type may convert into another in response to environmental challenges and recently reproduced in genetic models ([@bib2]; [@bib3]; [@bib6]; [@bib64]; [@bib59]). Moreover, the knockout of the IC specific transcription factor, *Foxi1* exhibited a cell type that co-expressed mixtures of IC (*Ca2*) and PC (*Aqp2*) proteins, implying that *Foxi1* restricted the otherwise facile interconversions of ICs to PCs ([@bib9]). Consequently, while many distinct cellular phenotypes are known to populate the collecting duct, the underlying logic that coordinates these cell types has not been uncovered.

A clue to the mechanisms that coordinate ICs and PCs was suggested by their stereotyped spatial patterning. Immunofluorescence analysis found rosette-like structures in the adult collecting duct, a pattern reminiscent of tissues governed by Notch mediated lateral inhibition ([@bib8]; [@bib26]; [@bib42]). In fact, recent studies have shown that manipulation of Notch signaling modifies the ratio of PCs and ICs ([@bib23]; [@bib20]; [@bib19]; [@bib41]) suggesting that not only *Foxi1* but also components of the Notch pathway are critical to determine cell type. However, the developmental context for these regulators is currently indeterminate, in part because of incomplete description of the developmental origin of IC and PC.

Here we show that IC-PC coordination is under control of a poorly studied transcription factor called *Tfcp2l1*. We found that *Tfcp2l1* induces the initial formation of a cellular intermediate which we call the 'double positive' mixed IC-PC cell. Thereafter *Tfcp2l1* regulates the formation of discrete ICs and PCs by both cell-autonomous and cell non-autonomous mechanisms. The latter includes the regulation of the *Jag1-Notch1* pathway in rosettes composed of ICs and PCs. These data indicate that UB tubules are patterned by Notch dependent interactions of neighboring cells rather than demarcated in nephron segments controlled by Notch signaling ([@bib13]).

In sum, coordinate development of ICs and PCs is linked by *Tfcp2l1* acting late in gestation in progenitors of the collecting duct. This mechanism explains the apparent reciprocal relationship in the relative abundance of ICs and PCs in the adult collecting duct ([@bib23]; [@bib20]) as well as their physiologic linkage. We suggest that coordination between ICs and PCs by *Tfcp2l1* is critical for homeostasis, since these cells co-regulate the balance of electrolytes, acid-base, and water.

Results {#s2}
=======

Expression of *Tfcp2l1* in the development of the distal nephron {#s2-1}
----------------------------------------------------------------

*Tfcp2l1* (also known as LBP-9 or CRTR-1) is a nuclear transcription factor and a member of the CP2 subfamily of the LSF/Grainyhead family ([@bib28]; [@bib66]; [@bib4]; [@bib63]; [@bib61]; [@bib57]). *Tfcp2l1* has been implicated in the maintenance of pluripotency networks of ES cells where it is targeted by both LIF ([@bib15]; [@bib34]; [@bib68]) and Wnt ([@bib66]). In addition, *Tfcp2l1* is implicated in the development of arborizing epithelial trees, including the collecting ducts ([@bib67]; [@bib43]). In fact, *Tfcp2l1* was detected at E11 in the primordium of the collecting ducts (the Wolffian Duct and the Ureteric Bud; data not shown), and then throughout its arborized *Krt8*^+^ stalks at E15-E18 ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) when *Tfcp2l1* appeared to localize exclusively to the nucleus. In adult collecting ducts (P60), *Tfcp2l1* was prominent in both PCs (*Krt8*^+^) and ICs (*Atp6v1b1*^+^; abbreviated *Atp6b1*) ([Figure 1B](#fig1){ref-type="fig"}), but demonstrated greater immunoreactivity in ICs than in PCs ([Figure 1C](#fig1){ref-type="fig"}). *Tfcp2l1* was also expressed in the Thick Limb of Henle and connecting segments of the nephron (data not shown), but its most persistent location was the collecting duct system.10.7554/eLife.24265.002Figure 1.*Tfcp2l1* is a nuclear protein expressed in the collecting ducts.(**A**) Immunofluorescence detection of *Tfcp2l1* (green) in stalks of ureteric-collecting ducts at E15 and at E18. Nuclear localization was prominent at E18. The ducts were identified by the uniform expression of *Krt8* (red). Bars = 5 µm. (**B**) In adult collecting ducts,*Tfcp2l1* (green) was expressed by both Intercalated Cells (IC), identified by immunodetection of *Atp6v1b1*, abbreviated *Atp6b1* (red), and Principal Cells (PC) identified by immunodetection of *Aqp2* (blue). Z-stack projection. Bar = 10 µm. (**C**) Quantification of *Tfcp2l1* immunoflourescence in adult collecting ducts normalized per measurement area. *Atp6b1*^+^ IC cells expressed higher levels of *Tfcp2l1* than did *Aqp2*^+^ PC cells.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.002](10.7554/eLife.24265.002)10.7554/eLife.24265.003Figure 1---figure supplement 1.Expression of *Tfcp2l1* message in the stalks of the ureteric bud (E15 mouse kidney; in-situ hybridization).All of the *Tfcp2l1*^+^ tubules are cross-sections of the collecting ducts.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.003](10.7554/eLife.24265.003)

Identification of IC-PC 'double positive' progenitors {#s2-2}
-----------------------------------------------------

In order to identify the cellular targets of *Tfcp2l1*, the development of collecting duct epithelia was characterized using signature proteins found in adult PCs and ICs. While the E13 and E15 collecting duct demonstrated homogeneous expression of proteins typical of PCs, there were rare cells co-expressing IC proteins (not shown). By E18 these cells became abundant and we designated them 'double-positive' progenitors, because they co-expressed IC and PC proteins (e.g. IC proteins: *Foxi1*^+^, *Atp6b1*^+^; together with PC proteins: *Calb1*^+^, *Krt8*^+^: [Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}). The 'double positive' phenotype was spatially restricted, because neighboring cells expressed PC but not IC proteins ([Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}). The 'double-positive' progenitors were also transient; by birth, IC and PC proteins were generally not co-expressed ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}; four independent mice for each immunofluorescence analysis) except in rare collecting duct cells ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).10.7554/eLife.24265.004Figure 2.'Double positive' progenitors populate the E18 collecting duct.(**A**) IC proteins were expressed at E18 in presumptive PC cells. Co-expression of *Atp6b1* (typical of ICs, red) and Calbindin (typical of PCs, blue) is shown in *Tfcp2l1*^+^ cells in the cortical region of the collecting duct. (white arrows) Bar = 10 µm. (**B**) Lineage of ICs and PCs was detected with genetic reporters. *HoxB7-Cre;mTmG* (green) marked every cell in the collecting duct including *AQP2*^+^ PC cells (red-yellow) and *Atp6b1*^+^ IC cells (blue-green). *Atp6b1-Cre;mTmG* labeled every IC cell (endogenous *Atp6b1*^+^; blue-green), as well as some *Aqp2*^+^ PCs (white arrows, yellow). *Atp6b1-Cre;mTmG*-negative PC cells are also found (*Aqp2*^+^, *Atp6b1*^-^, *Atp6b1-Cre;mTmG*^-^, red) (Bars= top 5 µm, bottom 20 µm).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.004](10.7554/eLife.24265.004)10.7554/eLife.24265.005Figure 2---figure supplement 1.Detection of 'double positive' precursors in the embryonic collecting ducts.(**A**,**B**) Detection of 'double positive' precursors in the embryonic collecting ducts. Immunofluorescence analysis of developing collecting ducts using markers of PCs (*Calb1* blue, *Krt8* red) and ICs (*Foxi1* green, *Atp6b1* green) cells. By E18, IC proteins are expressed in PC cells (i.e.*Foxi1*^+^ with *Calb1*^+^ or *Atp6b1*^+^ with *Krt8*^+^; n = 4 independent mice for each immunofluorescence analysis; Bars = 5 µm). (**C**) In contrast, PC (*Krt8*, red) and IC (*Atp6b1*, green) proteins were expressed in separate cells after birth (n = 4 independent mice for each immunofluorescence analysis; Bar = 10 µm).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.005](10.7554/eLife.24265.005)10.7554/eLife.24265.006Figure 2---figure supplement 2.Detection of rare 'double positive' cells in adult collecting duct using marker proteins Atpb1 (IC cells) and *Aqp2* (PC cells).Bar = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.006](10.7554/eLife.24265.006)10.7554/eLife.24265.007Figure 3.*Tfcp2l1* is necessary for the development of ICs.(**A**) Structure of mouse *Tfcp2l1* gene showing LoxP sites flanking the DNA-Binding CP2 domain (exon 3 and 4). (**B**) Control (*Tfcp2l1^f/f^*) and *Tfcp2l1* knockout kidneys (*Cdh16-Cre;Tfcp2l1^f/f^*) were analyzed for PC (*Aqp2* red) and IC (*Atp6b1* blue) proteins. Note that the deletion of *Tfcp2l1* replaced the normal patterning of IC and PC cells with a monotonous array of PC like cells (*Aqp2*^+^). Z-stack reconstruction. Bars = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.007](10.7554/eLife.24265.007)10.7554/eLife.24265.008Figure 3---figure supplement 1.Gross kidney morphology was preserved after the global deletion of *Tfcp2l1* (*EIIA-Cre;Tfcp2l1^f/f^*).Bars = 50 µM.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.008](10.7554/eLife.24265.008)10.7554/eLife.24265.009Figure 3---figure supplement 2.*Tfcp2l1* is necessary for the development of ICs.(**A,B**) The deletion of *Tfcp2l1* (*Cdh16-Cre;Tfcp2l1^f/f^*) abolished the alternating pattern of IC and PC cells and deleted multiple IC specific proteins. *Tfcp2l1* knockout deleted the cellular enzymes *Ca2* (red), *Atp6b1* (blue), and the transcription factor *Foxi1* (green), which are typically expressed by ICs. Conversely, *Tfcp2l1* knockout kidneys demonstrated prominent and uniform expression of PC markers *Aqp2* (red) and *Krt8* (green). (**A**) Bars = 10 µm; (**B**) Bars = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.009](10.7554/eLife.24265.009)

To further analyze the origin of ICs and PCs, we crossed cre-reporter (*mTmG*; [@bib40]) with cre-drivers that become active at different developmental stages of collecting duct development. We used *HoxB7-Cre*, which becomes active before the appearance of 'double positive' cells, and *Atp6b1-Cre*, which is active only after the expression of *Atp6b1* in ICs between E15-E18 ([@bib38]). All ICs and PCs were labeled in *HoxB7-Cre*/*mTmG* adult kidneys (P60; [Figure 2B](#fig2){ref-type="fig"}) confirming that ICs and PCs developed from a *HoxB7*^+^ ureteric progenitor cell. Surprisingly, *Atp6b1-Cre*/*mTmG* labeled not only *Atp6b1*^+^ ICs (74% of *GFP*-labeled cells were ICs) but also a subset of *Aqp2*^+^ PCs (24% of *GFP*-labeled cells were *Aqp2*^+^ cells expressing low levels of *Atp6b1*). In addition, rare (2%) *GFP*-labeled cells expressed equivalent levels of *Aqp2* and *Atp6b1*, typical of 'double positive' cells (n = 80 ducts in four independent mice were inspected for each genetic label). Therefore, all adult ICs and PCs derive from *HoxB7*^+^ progenitors and all adult ICs and at least some PCs derive from *HoxB7*^+^ progenitors that subsequently express *Atp6b1*^+^.

*Tfcp2l1* is required for epithelial patterning {#s2-3}
-----------------------------------------------

To determine whether *Tfcp2l1* is important for the development of 'double-positive' progenitors or for later stages of IC and PC development, we created a floxed allele flanking the CP2 domain ([Figure 3a](#fig3){ref-type="fig"}), and we used a set of cre-drivers to inactivate *Tfcp2l1* in a stage- and cell-specific manner. *EIIA-Cre* was used to delete *Tfcp2l1* early in development ([@bib29]), the *Cdh16*-Cre driver was used to inactivate *Tfcp2l1* throughout the distal nephron and collecting duct before ICs develop ([@bib53]), and *Atp6b1-Cre* was used for cell-specific deletion in maturing ICs ([@bib38]). In each case, the efficiency of *Tfcp2l1* inactivation was confirmed by immunostaining ([Figure 3B](#fig3){ref-type="fig"}). *EIIA-Cre;Tfcp2l1^f/f^* knockouts died quickly after birth when IC maturation was still ongoing (similar to published gene-trap; [@bib67]), but both *Cdh16-Cre* and *Atp6b1-Cre;Tfcp2l1^f/f^* knockouts survived to adulthood (P60).

*Tfcp2l1* deletion with *EIIA-Cre* or with *Cdh16-Cre* produced grossly normal kidneys at birth ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), except that all 'double positive' progenitors and all mature ICs were deleted, as measured by their signature proteins, *Foxi1*, *Ca2*, and *Atp6b1* which for example were reduced by \~89% (4.8 ± 1.9 *vs* 41.5 ± 15.1 *Atp6b1*^+^ cells per kidney section; n = 3 independent mice; p=0.0014; [Figure 3B](#fig3){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). In contrast, PC cell numbers and proteins demonstrated variable responses and were either mildly downregulated (e.g. 78 ± 23.6 *vs* 112.5 ± 22.6 *Aqp2*^+^ cells per kidney section; n = 3 independent mice; p=0.04; [Figure 3B](#fig3){ref-type="fig"}) or mildly upregulated (e.g. *Krt8*; [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). PCs also remained correctly polarized, displaying apical ROMK and basolateral *Cdh1* and *Aqp4*, indicating that *Tfcp2l1* did not regulate epithelial polarity in PCs (not shown). Hence, *Tfcp2l1* was critical to initiate the expression of IC signature genes which were first expressed in 'double positive' progenitors.

In contrast to the deletion of *Tfcp2l1* by *EIIA-Cre* and *Cdh1*6-Cre drivers which act before the appearance of IC cells, we found that deletion of *Tfcp2l1* with *Atp6b1*Cre resulted in a normal number and distribution of ICs and PCs at P14. By P60, however, there were fewer than half the number of ICs (14 ± 5.4 *vs*. 29 ± 13 *Atp6b1*^+^ cells per section or as a percentage of collecting duct cells; n = 3 independent kidneys each; p=0.01; [Figure 4A](#fig4){ref-type="fig"}). In fact, the surviving ICs demonstrated only faint *Atp6b1* staining which was co-expressed with PC protein *Krt8*. When we introduced the floxed *mTmG* Reporter with *Tfcp2l1*-flox and *Atp6b1-Cre*, and focused our analysis on *GFP*^+^ cells by measuring endogenous markers in single cells by spot imaging, we found that *GFP*^+^*Tfcp2l1*^+^ cells demonstrated IC (*Atp6b1*\>\>*Aqp2*) or PC (*Aqp2*\>*Atp6b1*) phenotypes, but *GFP*^+^ *Tfcp2l1*-deleted cells appeared strikingly similar to PCs (*Aqp2*\>*Atp6b1*; [Figure 4B](#fig4){ref-type="fig"}) or double positive cells (*Atp6b1*≈*Aqp2*).10.7554/eLife.24265.010Figure 4.IC specific deletion of *Tfcp2l1* (green) by *Atp6b1*Cre results in loss of IC cells.(**A**) Deletion of *Tfcp2l1* resulted in the widespread loss of IC and PC patterning. Only residual expression of *Atp6b1* (red) in *Krt8*^+^ (blue) PCs was detected in cortical collecting ducts (white arrows; n = 3 independent mice; Bars = 25 µm). (**B**) Cell fate analysis of *Tfcp2l1* knockout IC cells using genetic reporter (*Atp6b1-Cre;mTmG*). We analyzed single *GFP*^+^ cells in Control (*Atp6b1-Cre;Tfcp2l1^f/+^;mTmG*) and in Knockout (*Atp6b1-Cre;Tfcp2l1^f/f^;mTmG*) collecting ducts by spot imaging. In control kidneys, *GFP*^+^ cells were ICs or PCs (e.g. *GFP*^+^ ICs: *Atp6b1*\>*Aqp2* and *GFP*^+^ PCs: *Aqp2*\>*Atp6b1*), or expressed both markers in variable ratios (*Atp6b1*≈*Aqp2*). In contrast, in knockout kidneys, the majority of *GFP*^+^ cells appeared to be PC-like or double positives cell types (compare knockout with wild type profiles). (n = 20 *GFP*^+^ Control and n = 45 *Tfcp2l1* deleted *GFP*^+^ cells from representative images; n = 4 independent kidneys).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.010](10.7554/eLife.24265.010)

Taken together, *Tfcp2l1* was critical in the primary development of 'double positive' progenitors and the long-term maintenance of mature ICs which are otherwise capable of assuming a mixed or even a PC cell phenotype. In contrast, *Tfcp2l1* was not likely to mediate IC development by regulating their survival, because we failed to find the apoptosis marker activated caspase 3 in any of our models (data not shown).

Identification of *Tfcp2l1* target genes {#s2-4}
----------------------------------------

To identify transcriptional targets of *Tfcp2l1* that might explain IC regulation, we used an integrative approach that combined high-throughput data from two independent assays: (1) We found 843 differentially expressed genes in a comparison of *EIIA-Cre;Tfcp2l1^f/f^* knockout and *Tfcp2l1^f/f^* control P1 mouse kidneys (Affymetrix Microarrays analyzed by limma, n = 3, p\<0.05). According to GUDMAP, the comprehensive genitourinary development database ([@bib21], [www.gudmap.org](http://www.gudmap.org)), our analysis showed that 62% of downregulated genes were expressed either by UB, cortical or medullary collecting ducts or by the TALH including multiple subunits of the H^+^ATPase complex (*Atp6v0d2; Atp6b1; Atp6v1c2*) and IC specific *Foxi1*, *Ca12*, *Ca2*, *Aqp6* and *Oxgr1* ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}; [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}); (2) We found 6564 *Tfcp2l1*-bound genomic regions in P1 mouse kidney using ChIP-Seq ([Figure 5A](#fig5){ref-type="fig"}; [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Comparing the two datasets we found that *Tfcp2l1* bound both up and down regulated genes at the TSS ([Figure 5A,B](#fig5){ref-type="fig"}). In fact, in a global analysis of all *Tfcp2l1* peaks, 30% accumulated near the TSS within known promoters ([Figure 5C](#fig5){ref-type="fig"}). In addition these peaks demonstrated the established *Tfcp2l1* motif ([Supplementary file 4](#SD4-data){ref-type="supplementary-material"}) ([@bib11]). Moreover, cell type specific actions of *Tfcp2l1* were suggested in a comparison with *Tfcp2l1* ChIP-Seq from ES ([@bib11]) and from *Grhl2* ChIP-Seq in kidney ([@bib63]) which revealed little overlap with *Tfcp2l1* ChIP-Seq in kidney ([Figure 5D](#fig5){ref-type="fig"}). In contrast, a random set of genes that were not modulated by the *Tfcp2l* failed to show TSS enrichment ([Figure 5B](#fig5){ref-type="fig"}).10.7554/eLife.24265.011Figure 5.Identification of *Tfcp2l1* targets.(**A**) Identification of *Tfcp2l1* targets. Integration of knockout and *Tfcp2l1* ChIP-seq gene expression data obtained from P1 kidneys. Most of the genes significantly up or down regulated by *Tfcp2l1* (WT-*Tfcp2l1^f/f^* vs KO-EIIACre;*Tfcp2l1^f/f^*) demonstrated binding peak(s) mapping between +50 KB to −50 KB relative to the TSS for each gene. (**B**) *Tfcp2l1* peaks of both up and down regulated genes were enriched at the TSS in comparison with a random set of *Tfcp2l1* independent genes. (**C**) Genome wide annotation of *Tfcp2l1* peaks revealed that \~27% of peaks were within 1 kb of the TSS and 38% located within 10 kb from TSS. (**D**) Cell type specificity of *Tfcp2l1* ChIP peaks. Comparison of *Tfcp2l1* ChIP peaks in different models. P1 kidney (our study, Green) is compared with *Tfcp2l1* peaks identified in ES Cells ([@bib11], Red) and with *Grhl2* peaks identified in E18 kidney ([@bib63]), Tan color). Note the limited overlap between these datasets.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.011](10.7554/eLife.24265.011)10.7554/eLife.24265.012Figure 5---figure supplement 1.*Tfcp2l1* dependent genes localized to the collecting duct.Genes that were significantly downregulated by the knockout of *Tfcp2l1* (*EIIA-Cre;Tfcp2l1^f/f^*;\>1.25 fold downregulation; p\<0.05; n = 3 independent knockout and wild type mice) were localized with the help of GUDMAP (<http://www.gudmap.org/>). Most of these genes appeared to be highly expressed by the Ureteric Bud (UB), the Loop of Henle (HL), the cortical and medullary collecting ducts (CCD and MCD, respectively), and to a lesser extent by the proximal tubule, parallel with the expression pattern of endogenous *Tfcp2l1* (top row). Red color indicates expression; Blue color indicates no expression.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.012](10.7554/eLife.24265.012)10.7554/eLife.24265.013Figure 5---figure supplement 2.Differentially expressed genes from kidneys of *Tfcp2l1* knockouts (*EIIA-Cre;Tfcp2l1^f/f^*;\>1.25 fold up- or down-regulated; p\<0.05; n = 3 independent knockout and wild type mice).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.013](10.7554/eLife.24265.013)

The comparison between the two datasets also allowed us to identify the critical transcriptional targets of *Tfcp2l1*. Since *Tfcp2l1* is known as an activator ([@bib56]), we sought genes that were significantly downregulated in knockouts and contained a *Tfcp2l1*-DNA interaction site ±50 KB from the gene's transcriptional start site. Using this approach, we found that *Tfcp2l1* positively regulated expression of many IC genes including subunits B1 and D2 of the V-ATPase complex, *Oxgr1*, *Ca12*, *Slc4a1*, *Aqp6* and IC-specific transcription factor *Foxi1* ([Figure 5](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). In contrast, no known PC markers were represented in the downregulated gene set.

It has also been reported that *Tfcp2l1* is a repressor ([@bib47]). Consequently we analyzed genes that were upregulated in the knockouts and that demonstrated a *Tfcp2l1*-DNA interaction site ±50 KB from the gene's TSS. None of these genes were associated with a particular function or a cell-type in the distal nephron.

Taken together, *Tfcp2l1* directly controls genes that are critical for the function of IC cells (differentiation genes, V-ATPase, *Oxgr1* etc).

*Tfcp2l1* regulates *Jag1* and Notch signaling in the collecting duct {#s2-5}
---------------------------------------------------------------------

The analysis of our two datasets demonstrated significant over-representation of components of the Notch pathway suggesting that *Tfcp2l1* might regulate Notch signaling in ICs or in PCs.

We analyzed the Notch pathway using well characterized antibodies for Notch Ligands (*Jag1*, *Jag2*, *Dll1*, *Dll4*), Receptors (*Notch1-4*) and Notch Signaling States ('ON': characterized by detection of cleaved Notch and its target, nuclear *Hes1,* and 'OFF': characterized by detection of uncleaved Notch). We found that *Jag1* marked the development of ICs: *Jag1* and *Atp6b1* co-localize with Ktr8 in IC-PC 'double positive cells' at E18 ([Figure 6A](#fig6){ref-type="fig"}) and in the adult *Jag1* was specifically expressed by a subset of ICs called Pendrin^+^ β-ICs ([Figure 6B](#fig6){ref-type="fig"}). The localization of *Jag1* was specific because, α-ICs and PCs were *Jag1*^-^ ([Figure 6C](#fig6){ref-type="fig"}). In contrast, activated *Notch1* (NICD; Val1744) and activated nuclear *Hes1* were found in PCs (*Jag1*^-^,*Atp6b1*^-^,*Aqp2*^+^) immediately surrounding the *Jag1*^+^ β-ICs ([Figure 7](#fig7){ref-type="fig"}). Inactive, uncleaved *Notch1* (extracellular domain) was detected in other locations such as the basal membrane of some ICs, identified as *Krt8*^-^, *Jag1*^-^α-ICs ([Figure 8](#fig8){ref-type="fig"} and additional data, not shown). Therefore, the expression of *Jag1* and Notch activity correlated with the development of cell types: PCs ('Notch ON': *Jag1*^-^, Cleaved Notch1), β-IC ('Notch OFF' *Jag1*^+^, *Notch1*^-^), and α-IC ('Notch OFF' *Jag1*^-^, Uncleaved Notch1).10.7554/eLife.24265.014Figure 6.*Jag1* is a novel early marker of developing (E18) and adult (P60) IC cells and activated Notch is found in PCs(**A**) *Jag1* (green) co-expressed with *Atp6b1* (red) at the first appearance of 'double positive' cells. *Krt8* (purple) is expressed by all cells at this stage. (**B**) In the adult kidney, *Jag1* (green) is specifically expressed in a subset of IC cells called Pendrin^+^ β-ICs (red) (P60), but **C** not in other collecting duct cell types including *Aqp2*^+^ PC and *Aqp2*^-^ α-ICs. Nuclei, blue (**A**,**B**) Bars = 5 µm. (**C**) Bar = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.014](10.7554/eLife.24265.014)10.7554/eLife.24265.015Figure 7.(**A,B**) *Jag1-Notch1* signaling in the collecting duct. Activated Notch is found in PC cells adjacent to *Jag1*^+^*Atp6b1*^+^β-ICs. (**C**) Consistently, Notch target gene *Hes1* (red) was detected in *Aqp2*^+^ PC (green). **A, C** Bar = 10 µm, **B** Bar = 5 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.015](10.7554/eLife.24265.015)10.7554/eLife.24265.016Figure 8.*Tfcp2l1* is required for Notch signaling in collecting ducts.*Tfcp2l1* knockout (*Cdh16-Cre;Tfcp2l1^f/f^*) results in **A** depletion of *Jag1* (green) from *Krt8*^-^β-ICs (red) **B**. depletion of cell surface (inactive) *Notch1* (green) from *Krt8*^-^ α-ICs (red) **C** depletion of nuclear Hes (green) from *Krt8*^+^ PCs. (n = 4 independent mice for each immunodetection; Bars = 10 µm).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.016](10.7554/eLife.24265.016)10.7554/eLife.24265.017Figure 8---figure supplement 1.Sequential Chromatin IP.*Tfcp2l1* ChIP was followed by *Foxi1* or *Hes1* ChIP. Promoters of IC specific genes were analyzed in each ChIP by PCR. Three types of interactions were found in the selected promoters: *Tfcp2l1* alone, *Tfcp2l1*+*Foxi1* and *Tfcp2l1*+*Foxi1*+*Hes1* (n = 3 independent mice and ChIP).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.017](10.7554/eLife.24265.017)

To determine whether *Tfcp2l1* regulated the distinctive patterning of *Jag1* and *Notch1* expression, we examined *Cdh16-Cre;Tfcp2l1^f/f^* kidneys and found nearly complete deletion of *Jag1* in ICs and nuclear *Hes1* in PCs. In addition, Notch staining was deleted in the *Tfcp2l1* knockout collecting duct ([Figure 8](#fig8){ref-type="fig"}; n = 4 independent mice). These experiments suggested that *Jag1* and *Notch1* signaling were dependent on *Tfcp2l1*.

To determine whether *Tfcp2l1* might directly control Notch signaling, we examined ChIP analysis and found that *Tfcp2l1* directly bound the promoter of 18 Notch associated genes including *Jag1* (-904, -510), *Hes1* (-56202, -1823, 50028), *Hey1* (-127494, -336, 138049) and *Hey2* (-212) ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). To broaden this analysis, we examined *Tfcp2l1*-bound genomic regions for the enrichment of transcription factor motifs adjacent to the *Tfcp2l1* binding site (PWMErich using top 1000 *Tfcp2l1*-bound regions, [Supplementary file 4](#SD4-data){ref-type="supplementary-material"}). We found significant enrichment of motifs known to be targets of Notch signaling within ±20 bp from the *Tfcp2l1* peak center, including Hes- and Tfap-, Atoh-, and Tcf-families. We confirmed that promoters of IC-specific genes bound *Tfcp2l1*, *Hes1* and *Foxi1* by using *Tfcp2l1* ChIP followed by *Hes1* or *Foxi1* ChIP ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Considering that *Hes1* is a well-known repressor, these observations suggest a functional feedback loop from the Notch pathway to a subset of genes regulated by *Tfcp2l1*, potentially explaining why some IC genes are expressed at low levels in *Tfcp2l1*^+^*Hes1*^+^ PCs.

*Jag1* is required for cellular patterning and differentiation of the collecting ducts {#s2-6}
--------------------------------------------------------------------------------------

To analyze whether Notch signaling regulates the patterning of IC and PC proteins, we studied a conditional deletion of the Notch interacting domain exon 4 of Jag-1 ([@bib25]). We deleted *Jag1* with either *Cdh16-Cre* or *Atp6b1-Cre*-drivers and the deletions were confirmed at P60 by immunostaining ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}). *Cdh16-Cre;Jag1^f/f^* did not phenocopy *Cdh16-Cre;Tfcp2l1^f/f^*; in fact, ICs signature proteins were not only preserved in the *Jag1* knockout but were now widely co-expressed with PC proteins (e.g. *Tfcp2l1*^+^, *Atp6b1*^+^ with *Aqp2*^+^ or *Tfcp2l1*^+^, *Atp6b1*^+^ with *Krt8*^+^ or *Tfcp2l1*^+^, *Foxi1*^+^ with *Aqp2*^+^; [Figure 9](#fig9){ref-type="fig"}; [Figure 9---figure supplement 2](#fig9s2){ref-type="fig"}; n = 4 independent mice). Tubular structural failure was also found: tubules contained luminal debris ([Figure 9---figure supplement 2](#fig9s2){ref-type="fig"}) and collecting duct diameter was enlarged 28% in *Cdh16-Cre;Jag1^f/f^* (*Aqp4* staining facilitated the measurements: 30.1 ± 3.5 µm *vs* 23.5 ± 2 µm, SEM, n = 4 independent mice, p=2×10^−14^, [Figure 9---figure supplement 3](#fig9s3){ref-type="fig"}). *Krt8* was downregulated in these tubules, perhaps contributing to the structural failure. At later stages (P90) we observed hydronephrosis (3/4 mice), similar to another collecting duct-specific Notch-inactivation model ([@bib23]). These data suggest that while expression of IC proteins are 'upstream' of *Jag1*, their relative level in specific cells of the collecting duct is controlled by *Jag1* signaling.10.7554/eLife.24265.018Figure 9.*Jag1* regulates the distribution of IC proteins in the collecting ducts.Knockout of *Jag1* (*Jag1^f/f^;Cdh16-Cre*) resulted in diffuse expression of IC proteins **A** *Atp6b1* and **B** *Foxi1*. Expression of these proteins overlapped with *Aqp2* creating 'double positive' cells. (n = 4 independent mice; Bars = 10 µm).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.018](10.7554/eLife.24265.018)10.7554/eLife.24265.019Figure 9---figure supplement 1.Deletion of *Jag1* by *Cdh16-Cre*.Note the loss of *Jag1* staining. Examined at P1. Bars = 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.019](10.7554/eLife.24265.019)10.7554/eLife.24265.020Figure 9---figure supplement 2.Overview of the gross morphology of *Jag1* knockout kidneys.Knockout of *Jag1* (*Cdh16-Cre;Jag1^f/f^*) resulted in the uniform and overlapping expression pattern of *Atp6b1* (IC marker, blue) and *Krt8*^+^ (PC marker, red) in cortical collecting ducts. However, the deletion of *Jag1* did not affect the expression of *Tfcp2l1*. 'White' color tubules result from luminal debris. Bar = 50 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.020](10.7554/eLife.24265.020)10.7554/eLife.24265.021Figure 9---figure supplement 3.Jag1 is required for structural integrity of the collecting duct.(**A,B**) Deletion of *Jag1* (*Jag1^f/f^;Cdh16-Cre*) resulted in dilation of *Aqp2*^+^ (red) cortical and medullary collecting ducts. Phalloidin (blue) (n = 4 independent mice; Examined at P60. (**A**) Bars = 25 µm; (**B**) Bars = 50 µm).**DOI:** [http://dx.doi.org/10.7554/eLife.24265.021](10.7554/eLife.24265.021)10.7554/eLife.24265.022Figure 9---figure supplement 4.Deletion of *Jag1* in IC (*Jag1^f/f^;Atp6b1-Cre;mTmG*) resulted in a six fold increase in 'double positive' cells (from 2% to 12%; n = 3 independent mice).Only *Atp6b1*Cre driven *GFP*^+^ cells were assayed.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.022](10.7554/eLife.24265.022)

To dissect the role of Jag-Notch in collecting cell development at higher resolution, we generated an IC *Atp6b1-Cre;Jag1^f/f^;mTmG* mouse and analyzed the *GFP*-labeled knockout cells. We found an increase in 'double positive cells' (from 2% to 12%, p=0.004) and a decrease in *Aqp2*^+^ PC cells (24% to 12%; p=4.7E^−06^; n = 3 independent mice; [Figure 9---figure supplement 4](#fig9s4){ref-type="fig"}). Similar data were obtained when we acutely interrupted Notch signaling by treating explanted E15 mouse kidneys with the gamma-secretase inhibitor Compound E (100 nM, 48 hr, n = 6 independent cultures of mouse kidneys). The treatment generated striking 'double positive' cells at the tips of the Ureteric Bud (*Foxi1*^+^, *Atp6b1*^+^ and *Krt8*^+^; [Figure 10](#fig10){ref-type="fig"}). In sum, inactivation of *Jag1* disrupted IC and PC identity and arrested cells expressing inappropriate levels of IC and PC proteins.10.7554/eLife.24265.023Figure 10.Manipulation of Notch signaling in vivo.(**A**) Inhibition of Notch signaling upregulates *Foxi1* and promotes IC cell differentiation. Acute inhibition of Notch signaling in E15 kidneys with Compound E (48 hr) resulted in the differentiation of IC cells at the tips of the UB/Collecting Ducts. Note that the IC cells demonstrated a 'double-positive' phenotype with the co-expression of PC (*Krt8*^+^ blue) and IC (*Foxi1*^+^ red, *Atp6b1*^+^ green) proteins. (**B**) High power of Compound E treated kidneys (n = 6 independent mouse kidney cultures). (**A**) Bars = 50 µm and (**B**) Bar = 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.023](10.7554/eLife.24265.023)

Discussion {#s3}
==========

While most segments of the kidney have one type of epithelia, multiple cell types are found in the collecting ducts including a diverse population of ICs, PCs and 'double-positive' progenitor cells. While these cells differ in structure, gene expression and function, they cooperate to perform physiologic functions. For example, Na^+^ absorption by PCs via ENaC stimulates H^+^ excretion by ICs, and conversely the blockade of Na^+^ absorption in PCs by amiloride or by mutation of a subunit of the epithelial sodium channel results in the suppression of H^+^ secretion creating an 'electrogenic' renal tubular acidosis ([@bib10]; [@bib14]). Conversely, the deletion of bicarbonate transporters in ICs reduces the expression of Na+ channels in PCs ([@bib45]). The physical interactions between ICs and PCs not only promotes functional coupling of these cells by trans-epithelial gradients, but additionally permit juxtacrine signaling which regulates acid-base excretion (e.g. *CXCL12::CXCR4* ([@bib52]).

ICs and PCs may serve opposing but linked functions such as K^+^ excretion (PC) and K^+^ absorption (IC) ([@bib44]; [@bib27]). They may also serve independent roles which cannot be mutually compensated. For example, the decrease in PCs after Li treatment results in polyuria ([@bib12]) since PCs regulate water balance, while the decrease in ICs by *Tfcp2l1* deletion enhances kidney infection since ICs mediate urinary acidification and the production of a number of antimicrobials including *Lcn2*/NGAL ([@bib54]; [@bib43]). In sum, appropriate numbers of PCs and ICs are required for both physiologically linked and physiologically independent functions. Here we suggest that the integration of IC and PC populations is mediated by *Tfcp2l1* and *Jag1* and is reflected in their 'rosette' like architecture (e.g. [Figure 3](#fig3){ref-type="fig"}; [Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}).

*Tfcp2l1* and *Jag1* act on a primordial cell type which appears in the collecting duct between E15-E18 and expresses both IC and PC proteins ([Figure 2](#fig2){ref-type="fig"}; [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}). Descendants of these cells (tagged by *HoxB7-Cre* or *Atp6b1-Cre;mTmG*; [Figure 2B](#fig2){ref-type="fig"}) generated distinct ICs and PCs, yet even as canonical adult cells, they continued to express low levels of each other's signature proteins ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}; [Figure 4B](#fig4){ref-type="fig"}), and remain plastic enough to change their phenotypes from PC to IC or IC to PC in vitro ([@bib16]) and in vivo ([@bib44]; [@bib58]). In this setting the deletion of either *Tfcp2l1* (after it had already induced *Atp6b1*, [Figure 4](#fig4){ref-type="fig"}) or *Jag1* ([Figure 9](#fig9){ref-type="fig"}) demonstrated that cells initially destined to become ICs can fail to achieve their adult phenotype and demonstrate 'double positive' or even PC characteristics. In sum, the most likely explanation for our data is that collecting duct cells have the potential to choose either IC or PC fate and that the canonical cell types probably represent the extremes of a spectrum regulated by *Tfcp2l1* and *Jag1*.

*Tfcp2l1* appears to act on the IC-PC progenitors by both cell autonomous and cell non-autonomous mechanisms. Its cell autonomous activities were demonstrated both by an interaction of Tcfcp2l1 with IC specific genes ([Figure 5](#fig5){ref-type="fig"}; [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}) as well as loss of their expression in the *Tfcp2l1* knockout ([Figure 3](#fig3){ref-type="fig"}; [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}; [Figure 4](#fig4){ref-type="fig"}). These cell autonomous activities may explain the absence of all stages of IC development in a cell population destined to express PC-like characteristics. These data are reminiscent of the deletion of *Foxi1* ([@bib9]) which lies downstream of *Tfcp2l1*.

The cell non-autonomous role of *Tfcp2l1* was evidenced by a direct interaction of *Tfcp2l1* and the *Jag1* promoter (quantified in Supplemental Table 3) and by the loss of *Jag1* expression in *Tfcp2l1* knockouts ([Figure 8](#fig8){ref-type="fig"}). Hence, *Tfcp2l1* induced *Jag1* which we propose mediates cell-non-autonomous signaling from *Jag1*^+^ICs to *Notch1*^+^ PCs.

Notch signaling is known to control cell fate decisions and to pattern many different organs through lateral-inhibition ([@bib1]; [@bib35]). In an initially homogeneous cell population, some cells start to express more Notch ligand which activates Notch expressing neighboring cells. Notch activation downregulates the ligand, which in turn leads to reduced Notch signaling in the ligand expressing neighbor, locking the two neighboring cells into a Notch OFF-state (ligand-expressing) or a Notch ON-state (Notch expressing). Notch activation initiates gamma-secretase-mediated cleavage of Notch-receptor permitting the Notch intracellular domain (NICD) to translocate to the nucleus where it acts as a transcriptional co-activator with RBPJ. NICD-RBPJ complex regulates a set of BHLH transcription factors including *Hey1*, *Hey2*, *Hes1*, *Hes5*.

Notch-mediated generation of multiple cell types has been previously identified in the zebrafish pronephric duct ([@bib32]; [@bib33]) and in the Drosophila Malpighian tubule ([@bib62]) which are both phylogenetically related to the collecting duct of the mammalian nephron, as well as in functionally related cells in the frog skin ([@bib46]). Many components of the Notch signaling pathway were expressed in the embryonic mammalian collecting duct. Before E18 there was faint expression of *Jag1* and *Notch1* throughout the collecting duct (data not shown), but by E18 there was clear excess expression of *Jag1* in a subset of duct cells which displayed IC and PC proteins. Surrounding these IC progenitors were PCs with activated nuclear *Hes1*, a pattern which became distinct after birth ([Figure 6](#fig6){ref-type="fig"}; [Figure 7](#fig7){ref-type="fig"}). In sum, the classical lateral-inhibition paradigm of Notch signaling appears to be relevant to patterning collecting duct cell types.

'Notch-ON' signaling may be relevant to cell fate choices because while *Hes1* targets are not known in detail, TF binding site overrepresentation analysis (PWMEnrich; [@bib55]) of *Tfcp2l1* bound peaks demonstrated neighboring *Tfcp2l1* and *Hes1* binding sites, as well as combinatorial binding of *Tfcp2l1-Foxi1-Hes1* ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}) raising the possibility that *Hes1* signaling in PCs may negatively modulate *Tfcp2l1* and *Foxi1* targets. *Hes1* might repress IC genes in PC cells by enhancing chromatin modification enzymes since the inactivation of histone methyltransferase Dot1l appeared to convert PCs into ICs ([@bib65]). In sum, Notch signaling might antagonize *Tfcp2l1* in PC cells where Notch activates *Hes1*.

'Notch-OFF' in IC cells may result from the basolateral localization of Notch (perhaps making it sterically inaccessible to ligands), or perhaps as a result of the expression of NUMB in some ICs (not shown; [@bib36]). The 'Notch-OFF' state is likely to be critical for IC function because it may link *Tfcp2l1* to *Foxi1*. While *Tfcp2l1* might stimulate the expression of *Foxi1* directly (*Tfcp2l1* bound *Foxi1* at +50 kb from the TSS), the upregulation of *Foxi1* appeared to be a direct consequence of Notch-OFF because activated Notch signaling negatively regulated *Foxi1* ([@bib20]) and conversely Notch inactivation models (*Jag1* knockout and pharmacologic inhibition) generated diffuse expression of *Foxi1* ([Figure 9](#fig9){ref-type="fig"}, [Figure 10](#fig10){ref-type="fig"}). In addition, we found that *Foxi1* bound to the *Jag1* promoter ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), consistent with observations made in the endolymphatic duct cells of *Foxi1* knockouts where *Jag1* was absent ([@bib22]). Hence, while *Tfcp2l1* and *Foxi1* may act independently and synergistically to upregulate the IC phenotype ([@bib9]; [@bib60]), we expect that a positive regulatory loop between *Foxi1* and *Jag1* maintains high levels of *Jag1* expression in ICs, but conversely inhibits *Foxi1* in neighboring PCs. Hence, the induction of *Jag1* by *Tfcp2l1* suppressed IC gene expression in PCs.

Our data provide a developmental explanation for experiments demonstrating that the balance of cell types in the adult collecting duct can be modified by Notch signaling. For example, conditional inactivation of *Mib1* ([@bib23]; [@bib41]), a E3 ubiquitin-ligase that positively regulates Notch signaling by regulating Notch ligands, resulted in more ICs as did the inactivation of a cell surface protease, *Adam10* ([@bib20]), which regulates the cleavage and activation of Notch proteins. Conversely, overexpression of Notch intracellular domain ICD directed collecting duct cells towards a PC fate ([@bib23]). While these data were observed in the adult, we suggest that each of these experimental manipulations may have acted at the embryonic IC-PC 'double positive' stage. In other words, rather than a binary choices between canonical IC and PC phenotypes, a large body of literature may be explained by the notion that the manipulation of Notch signaling caused a failure to choose among competing programs of gene expression, producing the 'double positive' phenotype.

Our model has subtle differences with classical demonstrations of Notch signaling. In other developing organs, including the inner ear and intestine, classical negative feedback loops act in a paracrine manner between neighboring cells to inhibit the genes which induced the Notch ligands (e.g. *Ngn1* induces expression of *Dll1*, but Notch activation inhibits *Ngn1; Atoh1* activates *Dll1*/4, but *Dll1*/4 suppresses *Atoh1* \[[@bib39]; [@bib24]\]). In contrast, *Tfcp2l1* expression was inhibited only by two fold in *Hes1*^+^ PCs (IC\>PC). While this differential expression might contribute to cell speciation by driving higher levels of *Jag1* expression in ICs, we note that *Foxi1*, which is downstream of *Tfcp2l1*, is not only critical for *Jag1* expression, but it is reciprocally inhibited by Notch signaling ([Figures 9](#fig9){ref-type="fig"} and [10](#fig10){ref-type="fig"}). Consequently, both*Tfcp2l1* and *Foxi1*, rather than either alone, may mediate the Notch signaling.

A second distinction with the classical models was the response of PCs to the loss of *Hes1*. In other developing organs, loss of *Hes1* signaling resulted in a failure of tissue development (e.g. spinous skin cells; [@bib8]). In contrast, *Tfcp2l1* deletion and the failure of *Hes1* signaling did not block PC development, indicating that *Hes1* may play an inhibitory role in the collecting duct by preventing IC development in cells otherwise competent to become PCs. Rather than *Hes1,* additional Notch targets such as *Elf5* may mediate Notch dependent PC development ([@bib18]).

The plasticity of collecting duct cells was identified in the adult ([@bib51]); here we show that this plasticity reflects a developmental program that may remain active long after birth and is likely to permit adaptations to environmental cues. *Tfcp2l1* was found in a screen for transcription factors which induce epithelialization ([@bib7]; [@bib49]); Werth and Leete, Unpublished). However its key role lays in regulating the plasticity of collecting duct progenitors (*HoxB7*^+^, *Atp6b1*^+^, *Jag1*^+^ cells; Model [Figure 11](#fig11){ref-type="fig"}). *Tfcp2l1* provides essential directions for the initiation and refinement of this cell type via cell autonomous and non-cell autonomous mechanisms. As a consequence, it regulates the cellular diversity, which is the principal feature that distinguishes the collecting duct from other segments of the nephron.10.7554/eLife.24265.024Figure 11.Models.(**A**) Development of cellular diversity in the collecting duct. Initially, we found a monotonous expression of PC proteins at E13, and then a transitional stage (E15--E18) characterized by the appearance of 'double-positive' cells. After birth, these cells achieved distinct identities and assumed rosette-like patterning. Deletion of *Tfcp2l1* resulted in a monotonic cell type expressing PC cell, but not IC cell markers. Inactivation of *Jag1* in contrast resulted in the loss of cell identity and patterning, increasing the number of 'double-positive' cells typified by E18 collecting ducts. (**B**) Proposed model of cell-autonomous and non-cell-autonomous actions of *Tfcp2l1. Tfcp2l1* induces the expression of IC genes, including *Jag1*. Expression of *Jag1* triggers Notch signaling in adjacent PC cells. *Jag1* signaling results in activation of *Hes1* (Notch-ON) in PCs and conversely *Foxi1* expression in ICs (Notch-OFF). We envision that the combination of *Tfcp2l1* with either *Foxi1* or *Hes1* drives cell identity. Maintenance of this circuit may depend on an excess of *Tfcp2l1* in ICs ([Figure 1](#fig1){ref-type="fig"}) as well as the expression of *Foxi1* which is known to induce *Jag1*. Conversely, *Jag1* suppression of *Foxi1* ([Figures 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}) demonstrates a negative feedback loop in neighboring PCs.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.024](10.7554/eLife.24265.024)

Materials and methods {#s4}
=====================

*Animal models Tfcp2l1* conditional knockouts were generated by flanking exons 3, 4 and 5 (\~1.8 kb) with LoxP sites. These exons included the CP2 conserved functional domain and their deletion created an open reading frame shift. The targeting construct was generated by using a modified NCI BAC recombineering protocol. Briefly, mouse (C57) *Tfcp2l1* BAC clone (RP24-291G6, CHORI, Oakland, California) was recombineered using Loxp-Neomycin-Loxp (LNL) cassette with homologous arms upstream of exon 3 and Frt-Neomycin-Frt-Loxp (FNFL) cassette downstream of exon5. The *Tfcp2l1* -targeting BAC DNA was electroporated into mouse KV1 ES cells (generated by Columbia University Transgenic Facility), followed by neomycin selection. Neomycin-resistant ES clones were screened using PCR and Southern Blots and selected clones were microinjected into C57B6 blastocysts to generate chimeras. The *Tfcp2l1* chimeric mice were subsequently mated with *EIIa-flpe* C57B6 female mice for both germline transmission and flpe-based removal of the Frt-floxed neomycin cassette, which generated F1 *Tfcp2l1*-floxed mice. Cre mediated deletion was confirmed at the genomic level using PCR, at the RNA level using quantitative Real-Time PCR and at protein level using immunohistochemistry. *Tfcp2l1* knockout and wild type kidneys were assayed using Affymetrix Mouse Genome 430.2 microarrays.

*EIIA-Cre* (RRID:[IMSR_JAX:003724](https://scicrunch.org/resolver/IMSR_JAX:003724)), *Cdh16-Cre* (RRID:[IMSR_JAX:012237](https://scicrunch.org/resolver/IMSR_JAX:012237)) and *Jag1^f/f^* (RRID:[IMSR_JAX:010618](https://scicrunch.org/resolver/IMSR_JAX:010618)) were purchased from the Jackson Labs, Rosa26*mTmG* (RRID:[IMSR_JAX:007576](https://scicrunch.org/resolver/IMSR_JAX:007576)) was kindly provided by C Mendelsohn and *Atp6b1-Cre* was a gift from R Nelson, Utah. Rosa26*mTmG* genetic reporters express membrane-bound green fluorescein protein (*GFP*) upon Cre-mediated recombination ([@bib40]). *GFP* was detected with anti-*GFP* post-antigen retrieval. All rodents experiments were approved by Columbia University IACUC.

Chromatin immunoprecipitation {#s4-1}
-----------------------------

As described ([@bib63]), P1 mouse kidneys were cut into pieces and then sieved to single cells in DMEM. Chromatin was crosslinked and fragmented for 15 min (30 s stroke/30 s pause) using a Fisher Sonicator 450 (power 8; on 10 s and off 20 s for 6 min) to a fragment size of 100--500 bp. DNA concentration was measured by NanoDrop and then subjected to *Tfcp2l1* ChIP with anti-human *Tfcp2l1* (RRID:[AB_2202564](https://scicrunch.org/resolver/AB_2202564)) or goat IgG control (Jackson Immunoresearch). The ChIP antibody was extensively validated in ChIP-PCR assays. In brief, we used conservative *Tfcp2l1* binding site at Krt7 promoter to validate the performance of the *Tfcp2l1* antibody in a ChIP PCR assay. A ChIP Library was prepared according to the Illumina ChiPseq library preparation kit using size selection (150--250 bp). The library was sequenced on Illumina Genome Analyzer IIx (San Diego, California). Sequences were aligned to mm9 genome assembly using Bowtie ([@bib30]) and binding sites were detected using MACS ([@bib69]). We used GREAT ([@bib37]) for gene association/enrichment analysis. For motif analysis we used PWMEnrich (<http://www.bioconductor.org/packages/release/bioc/html/PWMEnrich.html>)

RNA extraction and cDNA synthesis, Affymetrix Arrays {#s4-2}
----------------------------------------------------

We isolated RNA using Qiagen RNAeasy micro kit, analyzed the isolate by Bioanalyzer (Agilent, Santa Clara, California), and synthesized cDNA using kits from Applied Biosystems. Preparation of templates and hybridization on Affymetrix Arrays was performed at the Columbia Genome Center. Differential gene expression was identified using R Limma (<https://bioconductor.org/packages/limma>). Induced genes were validated by QPCR using Sybr Green (Applied Biosystems, Forster City, California) and relative levels of mRNA expression were normalized to β-actin mRNA. Primer pairs were designed using Primer3 software (Whitehead Institute, MIT) and validated by product size ([Supplementary file 5](#SD5-data){ref-type="supplementary-material"}). P-values cut-offs (0.05 and 0.01) were chosen to generate datasets of comparable sizes.

Our data has been deposited with GEO, Accession Number GSE87769 (and Super Series: Accession Number GSE85325, GSE87744, GSE87752). *Tfcp2l1* ChIP-Seq data from ES cells was obtained from GEO, Accession Number GSE11431. *Grhl2* ChIP-Seq data from the kidney was obtained from GEO, Accession Number GSE24295.

In situ hybridization and immunocytochemistry {#s4-3}
---------------------------------------------

Tissues were prepared by intracardial perfusion with PBS followed by 1% PFA/PBS, 30% Sucrose/PBS, OCT (Tissue-Tek) and cryosectioned at 50 µm. Blocking and staining was performed in PBS/3% BSA/0.2% Triton X-100 solution. Controls and experimental samples were always placed on the same slide, stained in parallel and imaged with the same parameters using confocal Zeiss LSM510 Confocal Microscope (Columbia Core Facilities). We used confocal microscopy to reconstruct whole cells from the image stacks and estimated the amount of protein per cell by measuring total fluorescent signal. Antibodies are listed in [Supplementary file 5](#SD5-data){ref-type="supplementary-material"}. Data were analyzed using Fiji (ImageJ). Digoxigenin-labeled antisense riboprobes were generated from cDNAs using reverse primers containing a 5' T7 polymerase promoter sequence ([Supplementary file 5](#SD5-data){ref-type="supplementary-material"}; [@bib50]).
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###### Limma analysis of Affymetrix microarrays demonstrating differentially expressed genes in *EIIA-Cre;Tfcp2l1^f/f^* vs *Tfcp2l1^f/f^* kidneys (P1).

**DOI:** [http://dx.doi.org/10.7554/eLife.24265.025](10.7554/eLife.24265.025)

10.7554/eLife.24265.026

###### Identification of *Tfcp2l1* binding sites in P1 kidney using ChIP-seq (compared to IgG ChIP).

Analysis by MACS.

**DOI:** [http://dx.doi.org/10.7554/eLife.24265.026](10.7554/eLife.24265.026)

10.7554/eLife.24265.027

###### GREAT analysis of *Tfcp2l1* binding sites from [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} demonstrating significantly enriched pathways.

**DOI:** [http://dx.doi.org/10.7554/eLife.24265.027](10.7554/eLife.24265.027)

10.7554/eLife.24265.028

###### Motif analysis of top 1000 *Tfcp2l1* binding sites from P1 kidney (data from [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}).

**DOI:** [http://dx.doi.org/10.7554/eLife.24265.028](10.7554/eLife.24265.028)

10.7554/eLife.24265.029

###### PCR primers and antibodies.

**DOI:** [http://dx.doi.org/10.7554/eLife.24265.029](10.7554/eLife.24265.029)

Major datasets {#s7}
--------------

The following datasets were generated:

Werth et al.,2017,Identification of Tfcp2l1 target genes in the mouse kidney,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87769>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE87769)

Werth M,Barasch J,2017,Tfcp2l1 controls cellular patterning of the collecting duct.,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85325>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE85325)

Werth M,Barasch J,2017,RNA-Seq Gene Expression Analysis in Rat Metanephric Mesenchyme overexpressing Transcription Factor Tfcp2l1,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87744>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE87744)

Werth M,Barasch J,2017,Genome wide map of Tfcp2l1 binding sites from mouse kidney,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87752>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE87752)

The following previously published datasets were used:

Wei C,2008,Mapping of transcription factor binding sites in mouse embryonic stem cells,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE11431>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE11431)

Schmidt- Ott KM,Barasch J,Walentin K,Werth M,2010,Gene expression in epithelial and non-epithelial cells of renal origin,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24295>,Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE24295)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*TFCP2L1* Regulates the Patterning of Cells in the Collecting Duct of the Kidney\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Harry Dietz as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is a detailed analysis of the Tfcp2l1 knockout in the distal nephron. The authors reveal that this gene is necessary for promoting the intercalated cell phenotype within collecting ducts cells that are capable to be either principal or intercalated cells, at least partially through regulation of the Notch signaling pathway. These conclusions are drawn based on in situ antibody staining, RNA-Seq analysis and ChIP-seq. The authors devise a model whereby Tfcp21l interacts with Notch signaling to repress the intercalated cell fate in plastic collecting duct cells. This paper makes a number of important observations and establishes a new paradigm for collecting duct differentiation.

Essential revisions:

The work was found to be potentially interesting and worthy of publication in *eLife*, however there were major concerns from all three of the reviewers, all of which need to be addressed. They are:

1\) The writing needs to be polished. The data presentation is so dense that one cannot determine whether the conclusion is reasonable or not. There are innumerable small images presented to support their conclusions, but many of them are over processed, and display a confusing array of overlapping colors (although some individual wavelengths are shown in supplementary data, which is necessary), and from poorly defined tubule segments (in terms of their overall location in the kidney), that it is difficult to assess the overwhelming amount of data from the different animals and in vitro models used here. The overall major problem of information overload and seeming over interpretation of some of the images needs to be addressed. This will require serious editing and the removal of all but the essential data that support the hypothesis that Tfc2l1 is involved here.

2\) The authors might want to address in their (already too lengthy) Discussion, physiological contexts in which the cellular composition of the collecting duct has been shown to change. For example, with lithium exposure.

3\) Citations to figures in the text are incorrect. Some panels are never referred to. Some data is presented but the location of that data is not mentioned (Figure 4 is particularly bad). A lot of data is mentioned but there is no corresponding figure or supplemental figure. This needs to be corrected.

4\) A second issue is the experiments regarding the transfection of isolated MM with Tfcp2l1. This line of experimentation was very confusing to me until I read the Materials and methods section in which it was indicated that this was actually how this factor was discovered. However, that is not mentioned in the Results section. The reason this is confusing is because the manuscript focuses on the collecting ducts which are derived from a different lineage from the MM. Why they would use the MM instead of a collecting duct cell line is confusing. Further it is confusing as to how they are able to get cell types from both the MM lineage as well as the collecting duct lineage from this experiment. It appears as if they get an entire patterned nephron and collecting duct. Is Tfcp2l1 expressed in all these cells? Is this result different than if they treated with LIF? In the experiments where they compare the Tfcp2l1 transfected to GFP, do they treat with LIF (not clear from the Methods). If not, what are they comparing? An entire nephron to uninduced MM? If so, what is the relevance of these results? Without better explanation and rationale, I feel these results should be excluded from this paper.

5\) Some of the data if very difficult to see (Figure 1P-R, Figure 2G-J, 3C, 4A, B, most of Figure 6). In some cases, individual channels need to be shown. In others, higher magnification images would be of help.

6\) The authors need to clarify what Notch antibody they are using in their stainings. There are discrepancies between what they say in the text, how the label their figures and what the figure legends say.

7\) Figure 6A and B need to be divided up into distinct panels as each panel shows a different antibody combination from a different kidney (or at least region of the kidney). The single channel staining of pendrin is of low quality and hard to interpret. Co-stainings and/or higher mag should be shown.

8\) Figure 1, nuclear Tfcp staining is clear in the adults (E, F) but less so in the embryos (B, C, D). Do the authors have any better images? Also, is it clear that Tfcb is in all collecting duct cells in that levels are equal? Similarly, in 1M, the triple staining makes it hard to see whether Tfcb is in all cells. In 2E, it looks like the IC cells have more Tfcb for example.

9\) In Figure 3 the authors never show us the expression of Tfcp in the Adeno infected cultures, so it is really hard here to discern how much of the epithelia is due to Tfcb expression and how much is due to the supposed induction by LIF. Again, the multiple stains make it really hard to discern individual patterns. In 3D, it is hard for any reviewer to discern whether the Tfcb ChIP-seq peaks are meaningful and whether they localize to specific regions of genes or at the TSS. From the excel sheet, individual peaks may be significant but can the authors say something about the statistical significance of location of peaks? In other words, are peaks more likely to be near TSS rather than dispersed more randomly at target genes?

10\) In Figure 6, it would be nice to see Tfcb expression in the Jag1 KOs. In other words, does notch signaling alter levels of Tfcb and does this in turn reinforce more notch signaling to set boundaries between cell types?

11\) The model in Figure 7 assumes equal amounts of Tfcb, but this not clear. The transition from double positive to single positives, clearly require notch/jag1 and this depends on Tfcb, which is expressed in all cells (I think). But as notch signaling commences, do Tfcb levels remain the same or are they regulated by notch and does this then alter the amount of notch ligands to reinforce the pattern? The model assumes Hes1 and Foxi1 mediate the activation and repression, but again I am not sure Tfcb levels are equivalent in the two cell types.

10.7554/eLife.24265.044

Author response

*Essential revisions:*

*The work was found to be potentially interesting and worthy of publication in eLife, however there were major concerns from all three of the reviewers, all of which need to be addressed. They are:*

*1) The writing needs to be polished. The data presentation is so dense that one cannot determine whether the conclusion is reasonable or not. There are innumerable small images presented to support their conclusions, but many of them are over processed, and display a confusing array of overlapping colors (although some individual wavelengths are shown in supplementary data, which is necessary), and from poorly defined tubule segments (in terms of their overall location in the kidney), that it is difficult to assess the overwhelming amount of data from the different animals and in vitro models used here. The overall major problem of information overload and seeming over interpretation of some of the images needs to be addressed. This will require serious editing and the removal of all but the essential data that support the hypothesis that Tfc2l1 is involved here.*

We appreciate the comments and have spent much effort reorganizing a number of images, displaying separate confocal channels, removing (or moving to supplemental images) all but the most essential data rather than document all of the IC and PC proteins at different stages in a single image, and we describe the location of the images (cortical or medullary collecting ducts). In all we have removed 20 panels but at the same time we are now showing individual channels. In particular, E15 data is no longer shown because of very rare presence of double positive cells before E18.

We should mention that because we have reduced the complexity of the images, there are instances where we did have to indicate "data not shown". We are happy to replace those images-perhaps in other types of files -- according to your guidance.

Next, we simplified the writing of the paper along with clarification of the data presentation, including removing the section on induction in vitro, the section on additional segments of the nephron, especially the connecting segment, and revisions to reduce redundant statements. As a result, we reduced the manuscript by 500 words in order to focus on the Tfcp2l1 pathway.

*2) The authors might want to address in their (already too lengthy) Discussion, physiological contexts in which the cellular composition of the collecting duct has been shown to change. For example, with lithium exposure.*

We have expanded the section in the Discussion concerning medical settings in which IC and PC ratios might change.

In addition, these studies are ongoing in our lab but the connection between different diseases of collecting ducts (obstruction, UTI, Renal Tubular Acidoses, Li exposure) and the underlying signaling pathways remains unexplored. We suspect a variety of signaling paradigms are recruited in different medical settings. In [Author response image 1](#fig12){ref-type="fig"} we can see that PC cells have activated Wnt signaling (green), which most likely plays a role in Li exposure.10.7554/eLife.24265.030Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.24265.030](10.7554/eLife.24265.030)

Consequently, we comment on the few known physiological examples of perturbation of the IC-PC ratio, but there is much unknown.

*3) Citations to figures in the text are incorrect. Some panels are never referred to. Some data is presented but the location of that data is not mentioned (Figure 4 is particularly bad). A lot of data is mentioned but there is no corresponding figure or supplemental figure. This needs to be corrected.*

We have reformatted all of the images and we have carefully paired the text and the figures.

In order to cut down the amount of data (comment \#1), we had to remove some of the figures particularly the evidence of very rare IC cells at E15, multiple combinations of IC and PC marker proteins, and demonstrations of loss of protein expression in knockouts. Instead we have indicated "not shown". We are happy to replace any additional data as per the Editor's recommendation.

*4) A second issue is the experiments regarding the transfection of isolated MM with Tfcp2l1. This line of experimentation was very confusing to me until I read the Materials and methods section in which it was indicated that this was actually how this factor was discovered. However, that is not mentioned in the Results section. The reason this is confusing is because the manuscript focuses on the collecting ducts which are derived from a different lineage from the MM. Why they would use the MM instead of a collecting duct cell line is confusing. Further it is confusing as to how they are able to get cell types from both the MM lineage as well as the collecting duct lineage from this experiment. It appears as if they get an entire patterned nephron and collecting duct. Is Tfcp2l1 expressed in all these cells? Is this result different than if they treated with LIF? In the experiments where they compare the Tfcp2l1 transfected to GFP, do they treat with LIF (not clear from the Methods). If not, what are they comparing? An entire nephron to uninduced MM? If so, what is the relevance of these results? Without better explanation and rationale, I feel these results should be excluded from this paper.*

Thank you for these comments. The reviewer is correct that we identified Tfcp2l1 from an induction screen -- that is, we found that a single transcription factor can induce an entire patterned nephron and collecting duct. In fact, Tfcp2l1 is active without the addition of any other growth factors to metanephric mesenchymal cultures (LIF is not needed), and its induction rate approached 100% using two different adenoviral preparations. In the absence of growth factors, metanephric mesenchyme survives for one-two days, but after Tfcp2l1 induction, the mesenchyme expands and segmented nephrons appear. In our experiments, Tfcp2l1 was the only transcription transferred by Adenovirus to the mesenchyme that could reproduce LIF activity in rat metanephric mesenchyme.

Tfcp2l1 is expressed weakly in proximal segments of the nephron, more strongly in the Talh and most strongly and persistently in the collecting ducts. This may be an explanation for its remarkable inductive activity of both proximal and distal nephron segments. We think that the readout not only reflected the earlier expression of Tfcp2l1 throughout the nephron, but may reflect that both the ureteric bud and the metanephric mesenchyme derive from the intermediate mesoderm.

However, we appreciate that the induction of many types of epithelia including ureteric epithelia is not a classical finding in our field, and hence requires more explanation which is as the reviewer indicated is really distinct from the main findings of the paper. In addition, because our Tfcp2l1 knockout demonstrated striking loss of a specific cell type in the collecting duct rather than in other nephron segments, our paper focused on the collecting duct.

Consequently, we have removed the figure of kidney induction as well as all gene analyses that utilized Tfcp2l1induced epithelia. Fortunately, the gene analysis is unchanged. The only mention of the inductive activity of Tfcp2l1 is a brief comment in Discussion.

*5) Some of the data if very difficult to see (Figure 1P-R, Figure 2G-J, 3C, 4A, B, most of Figure 6).*

We have replaced these figures and have divided the images into their component pieces.

*In some cases, individual channels need to be shown. In others, higher magnification images would be of help.*

We now show individual confocal channels to clarify the images. We have added higher power images in Figure 2---figure supplement 1, Figure 3---figure supplement 1, Figure 4, Figure 6, Figure 7, Figure 8, Figure 9.

*6) The authors need to clarify what Notch antibody they are using in their stainings. There are discrepancies between what they say in the text, how the label their figures and what the figure legends say.*

The antibodies are listed in the Supplementary file 5. The Notch antibodies are R&D AF1057 and Abcam Ab8925. We have reviewed the figures and legends many times and hopefully there are no longer discrepancies.

*7) Figure 6A and B need to be divided up into distinct panels as each panel shows a different antibody combination from a different kidney (or at least region of the kidney). The single channel staining of pendrin is of low quality and hard to interpret. Co-stainings and/or higher mag should be shown.*

These figures have been changed and separate channels are now shown throughout the manuscript (e.g. new Figure 9). We have removed the low power image of pendrin staining substituting instead separate channels for ATPase in Figure 9.

*8) Figure 1, nuclear Tfcp staining is clear in the adults (E, F) but less so in the embryos (B, C, D). Do the authors have any better images? Also, is it clear that Tfcb is in all collecting duct cells in that levels are equal? Similarly, in 1M, the triple staining makes it hard to see whether Tfcb is in all cells. In 2E, it looks like the IC cells have more Tfcb for example.*

This is a very intriguing question concerning the regulation of Tfcp2l1 in different cell types. We changed Figure 1: E15 demonstrates an equivocal distribution of Tfcp2l1 but by E18 there is unequivocal nuclear localization co-incident with the first appearance of IC "double positive cells". Nuclear localization of Tfcp2l1 is also clear in the adult.

We now add data from spot imaging the adult collecting duct (Figure 1). It shows that IC cells, marked by Atp6b1, have a two-fold higher expression of Tfcp2l1, than do the PC cells, marked by Aqp2. Thank you for this question; we now mention in Discussion that a difference in Tfcp2l1 levels might contribute to the differentiation of IC-PC.

*9) In Figure 3 the authors never show us the expression of Tfcp in the Adeno infected cultures, so it is really hard here to discern how much of the epithelia is due to Tfcb expression and how much is due to the supposed induction by LIF. Again, the multiple stains make it really hard to discern individual patterns.*

Tfcp2l1 is an independent epithelial inducer, which is downstream of LIF. Consequently, no LIF is needed when Ad-Tfcp2l1 is added to metanephric mesenchyme. However, we removed the data from the paper concerning the inductive activity of the transcription factor according to suggestion \#4 and in order to better focus the paper on Tfcp2l1's role in the collecting duct.

*In 3D, it is hard for any reviewer to discern whether the Tfcb ChIP-seq peaks are meaningful and whether they localize to specific regions of genes or at the TSS. From the excel sheet, individual peaks may be significant but can the authors say something about the statistical significance of location of peaks? In other words, are peaks more likely to be near TSS rather than dispersed more randomly at target genes?*

Thank you for this question. We added a better plot in the figure (new Figure 5A) and indicated the accumulation of Tfcp2l1 peaks of both up and down regulated gene near the TSS (Figure 5B). We show that \~30% of peaks are within 1kb of the TSS and 40% are accounted for within 10kb. In contrast, randomly selected genes do not demonstrate accumulation of peaks near TSS.

*10) In Figure 6, it would be nice to see Tfcb expression in the Jag1 KOs. In other words, does notch signaling alter levels of Tfcb and does this in turn reinforce more notch signaling to set boundaries between cell types?*

Thank you for this question; it is an important addition to the article. The knockout of Tfcp2l1 abolishes Jag1 staining but the deletion of Jag1 does not suppress Tfcp2l1, at least as detected by IF. We have included a new figure from Jag1 knockouts, Figure 9 and supplements, which show reversion to "double positive cells" (Atp6b1^+^and Krt8^+^) in the collecting duct, but no loss of expression of Tfcp2l1. Consequently we have proposed that Tfcp2l1 is upstream of Jag1.

On the other hand, in answer to \#8, it is possible that Jag1 signaling suppresses Tfcp2l1 levels (PC cells had less Tfcp2l1; Figure 1) so there may be an additional feedback with promotes the differentiation of these cell types. We now mention this hypothesis in the Discussion.

*11) The model in Figure 7 assumes equal amounts of Tfcb, but this not clear. The transition from double positive to single positives, clearly require notch/jag1 and this depends on Tfcb, which is expressed in all cells (I think). But as notch signaling commences, do Tfcb levels remain the same or are they regulated by notch and does this then alter the amount of notch ligands to reinforce the pattern? The model assumes Hes1 and Foxi1 mediate the activation and repression, but again I am not sure Tfcb levels are equivalent in the two cell types.*

From the above \#10, we think that Jag-Notch are downstream of Tfcp2l1 and hence we do not expect variation of Tfcp2l1 with Jag1 signaling. By using an in situ RNA labeling technique-pulldown assay that we developed (Unpublished), we do not find much difference in RNA content of these cells. However, to examine this question, we used spot imaging of the collecting duct and we measured a two- fold difference in immunodetectable Tfcp2l1.

We emphasized in the Discussion that there is evidence for feedback loops at the level of Foxi1 and Jag1. While our data are strongest for this hypothesis, our new data suggests that modulation of Tfcp2l1 may enhance the distinction between IC and PC as well. Thank you for pointing out this possibility.

[^1]: These authors contributed equally to this work.
